THE PHOSPHORYLATION STATE OF THE MICROTUBULE-ASSOCIATED PROTEIN TAU AS AFFECTED BY GLUTAMATE, COLCHICINE AND BETA-AMYLOID IN PRIMARY RAT CORTICAL NEURONAL CULTURES
Dr. Davis et al., THE PHOSPHORYLATION STATE OF THE MICROTUBULE-ASSOCIATED PROTEIN TAU AS AFFECTED BY GLUTAMATE, COLCHICINE AND BETA-AMYLOID IN PRIMARY RAT CORTICAL NEURONAL CULTURES, Biochemical journal, 309, 1995, pp. 941-949
The effects of the excitatory amino acid glutamate, the microtubule de
stabilizing agent colchicine, and beta(25-35)-amyloid peptide on the p
hosphorylation state of tau were studied in rat cortical neurons in pr
imary culture. Using immunocytochemistry and Western-blot analysis, we
demonstrated that a proportion of tau in these cultures is normally h
ighly phosphorylated, but mast of this tau fraction is dephosphorylate
d after treatment of the cultures with glutamate or colchicine, but no
t with beta-amyloid; the glutamate- and colchicine-induced changes in
tau phosphorylation commenced before cell death, as assessed by releas
e of lactate dehydrogenase, Dephosphorylation of tau was readily revea
led by using the monoclonal antibodies Tau.1 and AT8, which have phosp
hate-sensitive epitopes that both centre around serine-199 and -202 (n
umbering of the largest tau isoform). On Western blots and by immunocy
tochemistry, AT8 labelling strongly decreased after glutamate and colc
hicine treatments, whereas Tau.1 staining was more intense. Neurofilam
ent monoclonal antibodies, including RT97, 8D8, SMI31 and SMI310, all
additionally known to recognize tau in a phosphorylation-dependent man
ner, also demonstrated that glutamate and colchicine treatments of the
cultures induced a dephosphorylation of tau. We also showed immunocyt
ochemically that there is an increase in tau immunoreactivity in neuro
nal perikarya in response to glutamate and colchicine treatment, and t
his occurs concomitantly with the dephosphorylation of tau. Treatment
of the primary rat cortical neuronal cultures with beta(25-35)-amyloid
peptide, under conditions which induce neuronal degeneration, did not
induce a change in tau phosphorylation, and failed to act synergistic
ally with glutamate to produce an increase in dephosphorylation of tau
over that produced by glutamate treatment alone. These findings demon
strate that glutamate and colchicine induce tau dephosphorylation, as
opposed to increased tau phosphorylation, which would be more indicati
ve of Alzheimer-type neurodegeneration.